Clinical trial
Early Performance in Patients With Type-II-Diabetes Mellitus Under New Treatment With SGLT-2-Inhibitors Compared to Control Groups.
NCT03422263 is registered in ClinicalTrials.gov with Berner Klinik Montana as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Performance in Patients With Type-II-Diabetes Mellitus Under New Treatment With SGLT-2-Inhibitors Compared to Control Groups.
- Lead sponsor
- Berner Klinik Montana
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- September 30, 2020
- Enrollment
- 450 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.